TD Ameritrade Stock Price, News & Analysis (NASDAQ:AMTD)

TD Ameritrade trades on the NASDAQ under the ticker symbol "AMTD."

TD Ameritrade declared a quarterly dividend on Monday, July 22nd. Shareholders of record on Tuesday, August 6th will be given a dividend of $0.30 per share on Tuesday, August 20th. This represents a $1.20 annualized dividend and a yield of 3.26%. The ex-dividend date is Monday, August 5th. View TD Ameritrade's Dividend History.

TD Ameritrade Holding Corp. (NASDAQ:AMTD) announced its quarterly earnings data on Monday, July, 22nd. The financial services provider reported $1.04 EPS for the quarter, topping the Zacks' consensus estimate of $0.97 by $0.07. The financial services provider had revenue of $1.49 billion for the quarter, compared to analyst estimates of $1.47 billion. TD Ameritrade had a net margin of 36.07% and a return on equity of 27.13%. TD Ameritrade's revenue was up 7.9% on a year-over-year basis. During the same quarter last year, the business posted $0.89 earnings per share. View TD Ameritrade's Earnings History.

TD Ameritrade is scheduled to release their next quarterly earnings announcement on Monday, October 21st 2019. View Earnings Estimates for TD Ameritrade.

TD Ameritrade will be holding an earnings conference call on Monday, October 21st at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

12 equities research analysts have issued 1-year price targets for TD Ameritrade's stock. Their forecasts range from $27.00 to $60.00. On average, they expect TD Ameritrade's share price to reach $41.90 in the next twelve months. This suggests a possible upside of 13.9% from the stock's current price. View Analyst Price Targets for TD Ameritrade.

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for TD Ameritrade in the last year. There are currently 4 sell ratings, 6 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for TD Ameritrade.

Headlines about AMTD stock have trended somewhat negative this week, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. TD Ameritrade earned a news sentiment score of -1.5 on InfoTrie's scale. They also assigned headlines about the financial services provider a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for TD Ameritrade.

TD Ameritrade saw a increase in short interest during the month of September. As of September 30th, there was short interest totalling 8,780,000 shares, an increase of 32.6% from the August 30th total of 6,620,000 shares. Based on an average trading volume of 3,960,000 shares, the short-interest ratio is currently 2.2 days. Currently, 1.8% of the company's stock are sold short. View TD Ameritrade's Current Options Chain.

Some companies that are related to TD Ameritrade include Goldman Sachs Group (GS), Morgan Stanley (MS), BlackRock (BLK), Charles Schwab (SCHW), Credit Suisse Group (CS), Nomura (NMR), MarketAxess (MKTX), Raymond James (RJF), SEI Investments (SEIC), Jefferies Financial Group (JEF), Stifel Financial (SF), Virtu Financial (VIRT), Navient (NAVI), Future Healthcare of America (FUTU) and Futu (FHL).

Based on aggregate information from My MarketBeat watchlists, some companies that other TD Ameritrade investors own include CA (CA), BlackRock (BLK), Constellation Software (CSU), Endologix (ELGX), Intact Financial (IFC), Chipotle Mexican Grill (CMG), Athabasca Oil (ATH), Micron Technology (MU), NIC (EGOV) and Aegean Marine Petroleum Network (ANW).

TD Ameritrade's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Baltimore Washington Financial Advisors Inc. (0.03%), Robeco Institutional Asset Management B.V. (0.02%), Zurcher Kantonalbank Zurich Cantonalbank (0.01%), Altman Advisors Inc. (0.01%), Three Peaks Capital Management LLC (0.01%) and CIBC Private Wealth Group LLC (0.01%). Company insiders that own TD Ameritrade stock include Joseph H Moglia, Peter J Desilva and Thomas A Nally. View Institutional Ownership Trends for TD Ameritrade.

AMTD stock was sold by a variety of institutional investors in the last quarter, including Robeco Institutional Asset Management B.V., Envestnet Asset Management Inc., Zurcher Kantonalbank Zurich Cantonalbank , CIBC Private Wealth Group LLC, Douglas Lane & Associates LLC, State of Alaska Department of Revenue, Baltimore Washington Financial Advisors Inc. and First Hawaiian Bank. View Insider Buying and Selling for TD Ameritrade.

AMTD stock was purchased by a variety of institutional investors in the last quarter, including Three Peaks Capital Management LLC, Campbell & CO Investment Adviser LLC, Dfpg Investments Inc., Polianta Ltd, Cerebellum GP LLC, Cerebellum GP LLC, Sumitomo Mitsui DS Asset Management Company Ltd and Meeder Asset Management Inc.. View Insider Buying and Selling for TD Ameritrade.

Shares of AMTD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of AMTD stock can currently be purchased for approximately $36.79.

TD Ameritrade has a market capitalization of $20.18 billion and generates $5.45 billion in revenue each year. The financial services provider earns $1.47 billion in net income (profit) each year or $3.34 on an earnings per share basis. TD Ameritrade employs 9,183 workers across the globe.View Additional Information About TD Ameritrade.

The official website for TD Ameritrade is http://www.amtd.com/.

TD Ameritrade's mailing address is 200 SOUTH 108TH AVENUE, OMAHA NE, 68154. The financial services provider can be reached via phone at 800-669-3900 or via email at [email protected]